EIF4E expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.326800E-01
Normal-vs-Stage2
9.615600E-01
Normal-vs-Stage3
4.973800E-01
Normal-vs-Stage4
5.524600E-01
Stage1-vs-Stage2
4.467200E-01
Stage1-vs-Stage3
2.074400E-01
Stage1-vs-Stage4
7.066800E-01
Stage2-vs-Stage3
4.328600E-01
Stage2-vs-Stage4
2.281400E-01
Stage3-vs-Stage4
3.135600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.795400E-01
Normal-vs-AfricanAmerican
7.637000E-01
Normal-vs-Asian
6.891000E-01
Caucasian-vs-AfricanAmerican
6.451400E-01
Caucasian-vs-Asian
3.425000E-01
AfricanAmerican-vs-Asian
3.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.624400E-01
Normal-vs-Female
6.917200E-01
Male-vs-Female
8.800100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.856000E-01
Normal-vs-Age(41-60Yrs)
4.487800E-01
Normal-vs-Age(61-80Yrs)
8.574800E-01
Normal-vs-Age(81-100Yrs)
9.023600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.304400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.466600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.852800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.561700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.057810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.610800E-01
Normal-vs-Daily Drinker
8.554200E-01
Normal-vs-Weekly Drinker
6.628800E-01
Normal-vs-Occasional Drinker
4.003400E-01
Normal-vs-Social Drinker
9.443000E-01
Non Drinker-vs-Daily Drinker
8.365600E-01
Non Drinker-vs-Weekly Drinker
7.769600E-01
Non Drinker-vs-Occasional Drinker
2.397900E-02
Non Drinker-vs-Social Drinker
5.069400E-01
Daily Drinker-vs-Weekly Drinker
6.753000E-01
Daily Drinker-vs-Occasional Drinker
6.387900E-02
Daily Drinker-vs-Social Drinker
6.613800E-01
Weekly Drinker-vs-Occasional Drinker
3.633800E-02
Weekly Drinker-vs-Social Drinker
4.576600E-01
Occasional Drinker-vs-Social Drinker
2.533400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.221600E-01
Normal-vs-Grade 2
3.831600E-02
Normal-vs-Grade 3
7.262000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.499000E-01
Grade 1-vs-Grade 3
7.845800E-01
Grade 1-vs-Grade 4
2.221600E-01
Grade 2-vs-Grade 3
5.379000E-01
Grade 2-vs-Grade 4
3.831600E-02
Grade 3-vs-Grade 4
7.262000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.880200E-01
Normal-vs-NonDiabetic
8.925600E-01
Diabetic-vs-NonDiabetic
1.018440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.256800E-01
Normal-vs-NoPancreatitis
9.586600E-01
Pancreatitis-vs-NoPancreatitis
3.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.414600E-01
Normal-vs-N1
8.936200E-01
N0-vs-N1
7.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.364400E-01
Normal-vs-TP53-NonMutant
9.855000E-01
TP53-Mutant-vs-TP53-NonMutant
2.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
